What changed
Researchers added an AI-enabled digital stethoscope and an AI reading of a standard 12-lead ECG to obstetric care. A positive AI screen was checked with an echocardiogram—the imaging test used to confirm whether the heart's pumping function was reduced.
The digital-stethoscope pathway identified left-ventricular systolic dysfunction in 4.1% of participants, compared with 2.0% under usual care. That is 24 people detected in the AI-guided group versus 12 in the control group.
What this could change for you
Pregnancy-related cardiomyopathy can look like ordinary pregnancy or postpartum symptoms: fatigue, swelling, and shortness of breath. A low-cost screening tool could help clinicians decide who needs a full heart scan sooner.
The important word is screening. The AI did not make the final diagnosis; it moved more people toward confirmatory care.
What it does not prove
The study took place in Nigeria, where reported rates of peripartum cardiomyopathy are unusually high. All participants identified as Black, so broader validation is still needed.
Finding more cases does not yet prove that the pathway improves survival or long-term heart health. It also depends on access to echocardiography and treatment after a positive screen.
The bottom line
AI turned a familiar clinical tool into a more sensitive front door for heart screening. That could matter most where specialists and imaging are limited, but the result still needs testing in other health systems.
Primary research
Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial
Nature Medicine · 2024 · DOI 10.1038/s41591-024-03243-9
